Neurotransmitter Transporters: Recent Progress

Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter

Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996) · Nature · doi:10.1038/379606a0 · Cited by 2,476

Dopamine as a Prolactin (PRL) Inhibitor

Ben-Jonathan, N., & Hnasko, R. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.6.0451 · Cited by 983

Role of Serotonin in the Paradoxical Calming Effect of Psychostimulants on Hyperactivity

Gainetdinov, R. R., Wetsel, W. C., Jones, S. R., Levin, E. D., Jaber, M., & Caron, M. G. (1999) · Science · doi:10.1126/science.283.5400.397 · Cited by 885

Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic

Zhou, Q.-Y., & Palmiter, R. D. (1995) · Cell · doi:10.1016/0092-8674(95)90145-0 · Cited by 731

Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport

Sulzer, D., Chen, T., Lau, Y., Kristensen, H., Rayport, S., & Ewing, A. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-05-04102.1995 · Cited by 688

Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: Heterogeneity owing to diagnostic subtype and severity

Waldman, I. D., Rowe, D. C., Abramowitz, A., Kozel, S. T., Mohr, J. H., Sherman, S. L., Cleveland, H. H., Sanders, M. L., Gard, J. M. C., & Stever, C. (1998) · The American Journal of Human Genetics · doi:10.1086/302132 · Cited by 462

Molecular Physiology of Norepinephrine and Serotonin Transporters

Blakely, R. D., De Felice, L. J., & Hartzell, H. C. (1994) · Journal of Experimental Biology · doi:10.1242/jeb.196.1.263 · Cited by 404

Striatal dopamine neurotransmission: Regulation of release and uptake

Sulzer, D., Cragg, S. J., & Rice, M. E. (2016) · Basal Ganglia · doi:10.1016/j.baga.2016.02.001 · Cited by 382

Role of norepinephrine in the pathophysiology and treatment of mood disorders

Ressler, K. J., & Nemeroff, C. B. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00127-4 · Cited by 307

Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity

Morón, J. A., Zakharova, I., Ferrer, J. V., Merrill, G. A., Hope, B., Lafer, E. M., Lin, Z. C., Wang, J. B., Javitch, J. A., Galli, A., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-24-08480.2003 · Cited by 262

Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter

Bossé, R., Fumagalli, F., Jaber, M., Giros, B., Gainetdinov, R. R., Wetsel, W. C., Missale, C., & Caron, M. G. (1997) · Neuron · doi:10.1016/s0896-6273(00)80353-0 · Cited by 203

Serotonergic system and attention deficit hyperactivity disorder (ADHD): a potential susceptibility locus at the 5-HT1B receptor gene in 273 nuclear families from a multi-centre sample

Hawi, Z., Dring, M., Kirley, A., Foley, D., Kent, L., Craddock, N., Asherson, P., Curran, S., Gould, A., Richards, S., et al. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001048 · Cited by 175

Neuroprotective effects of the green tea components theanine and catechins

Kakuda, T. (2002) · Biological & Pharmaceutical Bulletin · doi:10.1248/bpb.25.1513 · Cited by 165

Differential psychostimulant-induced activation of neural circuits in dopamine transporter knockout and wild type mice

Trinh, J. V., Nehrenberg, D. L., Jacobsen, J. P. R., Caron, M. G., & Wetsel, W. C. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00165-9 · Cited by 113

Mesolimbic dopamine super-sensitivity in melanin-concentrating hormone-1 receptor-deficient mice

Smith, D. G., Tzavara, E. T., Shaw, J., Luecke, S., Wade, M., Davis, R., Salhoff, C., Nomikos, G. G., & Gehlert, D. R. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4079-04.2005 · Cited by 103

Neurosteroid Actions in Memory and Neurologic/Neuropsychiatric Disorders

Ratner, M. H., Kumaresan, V., & Farb, D. H. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00169 · Cited by 96

Stimulant drugs

Santosh, P. J., & Taylor, E. (2000) · European Child & Adolescent Psychiatry · doi:10.1007/s007870070017 · Cited by 94

Recent Progress in Understanding the Pathophysiology of Post-Traumatic Stress Disorder: Implications for Targeted Pharmacological Treatment

Bailey, C. R., Cordell, E., Sobin, S. M., & Neumeister, A. (2013) · CNS Drugs · doi:10.1007/s40263-013-0051-4 · Cited by 89

Review: Genetics of Attention Deficit/Hyperactivity Disorder

Wallis, D., Russell, H. F., & Muenke, M. (2008) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsn049 · Cited by 86

Familial orthostatic tachycardia due to norepinephrine transporter deficiency

ROBERTSON, D., FLATTEM, N., TELLIOGLU, T., CARSON, R., GARLAND, E., SHANNON, J. R., JORDAN, J., JACOB, G., BLAKELY, R. D., & BIAGGIONI, I. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03703.x · Cited by 64

Gas sensing and electrochemical properties of rare earthferrite, LnFeO 3 (Ln = Nd, Sm)

Anajafi, Z., Naseri, M., & Neri, G. (2020) · Ceramics International · doi:10.1016/j.ceramint.2020.07.139 · Cited by 34

Astrocytic transporters in Alzheimer's disease

Ugbode, C., Hu, Y., Whalley, B., Peers, C., Rattray, M., & Dallas, M. L. (2017) · Biochemical Journal · doi:10.1042/bcj20160505 · Cited by 25

Correlation of Parkinson's disease severity and duration with123I-FP-CIT SPECT striatal uptake

Benamer, H. T. S., Patterson, J., Wyper, D. J., Hadley, D. M., Macphee, G. J. A., & Grosset, D. G. (2000) · Movement Disorders · doi:10.1002/1531-8257(200007)15:4<692::aid-mds1014>3.0.co;2-v